The ChAdOx1 nCov-19 coronavirus vaccine produced by the Oxford University partnering with the British-Sweden company AstraZeneca has been approved by the UK government for emergency use on the 30th of december 2020 as recommended by the Medicine and Healthcare Products Regulatory Agency (MHRA). The Oxford COVID-19 vaccine was made from a weakened adenovirus that often cause common cold in chimpanzee and it has been genetically modified that it is completely safe and doesn’t cause harm in those that received the vaccine.
The professor of Vaccinology at the University of Oxford, Professor Sarah Girlbert said “This is a day for the team developing the vaccine to celebrate after a year of extremely hard work with difficult circumstances. Now that the first authorisation on use of the vaccine outside the clinical trials have been granted we still have more to do and will continue to provide more data to multiple regulatory authorities, until we are able to see that the vaccine is being used to save lives around the world.
“Today is an important day for millions of people in UK who will get access to this new vaccine, it has been shown to be effective, well tolerated, simple to administer and is supplied by AstraZeneca at no profit. We would like to thank our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants” Said the Chief Executive Officer of AstraZeneca Pascal Soriot.
The Vice-chancellor at the University of Oxford, Professor Louise Richardson said ‘This is a great day for British science and a great day for university everywhere. Above all, it is a great day for many people whose life will be saved by the vaccine. We are greatly indebted to those who have designed, developed, manufactured and evaluated ChAdOx1.
The Oxford/AstraZeneca COVID-19 vaccine inoculation have started in the UK on the 4th of January 2021 and the first person to receive it was a 82 year old man named Bryan Pinker. He said ‘I’m so pleased to be getting the COVID-19 vaccine today and really proud it is one that was infected in Oxford’ in a statement released by the UK NHS England official Twitter account.
The coronavirus vaccine produced by the Oxford University in partnership with AstraZeneca comes into doses and offers up to 70.4 in the combined doses. According to the Joint Committee on Vaccination and Immunisation (JCVI) people who get the vaccine will receive their second dose after12 weeks of taking the first dose so as to ensure long term protection.